ZNTL logo

ZNTLZentalis Pharmaceuticals Inc

$3.66
$0.21
(5.43%)
Today
Closed $3.66
$0.0569
(1.55%)
After Hours
Updated: 07:40 PM EDT
Reported EarningsMay 12
Mkt Cap$275.49M
Vol1.01M

About

Zentalis Pharmaceuticals, Inc. is a clinical oncology innovator developing an oral, non-chemotherapy, biomarker-driven treatment approach for ovarian cancer and multiple tumor types. The therapeutics development and biomarker expertise is advancing monotherapy and combination studies of its investigational potential first-in-class WEE1 inhibitor, azenosertib. It is focused on translating WEE1 science into clinical practice, aiming to equip physicians with a targeted, orally available medicine that enhances treatment experience, choice, and outcomes. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
106

Frequently Asked Questions

What is Market Cap of Zentalis Pharmaceuticals Inc?
What is the 52-week high for Zentalis Pharmaceuticals Inc?
What is the 52-week low for Zentalis Pharmaceuticals Inc?
What is Zentalis Pharmaceuticals Inc stock price today?
What was Zentalis Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Zentalis Pharmaceuticals Inc?
What is the Price-to-Book ratio of Zentalis Pharmaceuticals Inc?
What is the 50-day moving average of Zentalis Pharmaceuticals Inc?
How many employees does Zentalis Pharmaceuticals Inc have?

Advertisement|Remove ads.